Study #2025-1358
A modular phase 2, single-arm, multicenter, open-label study to evaluate the efficacy and safety of Surovatamig (AZD0486) in participants with relapsed or refractory B-cell non-Hodgkin lymphoma (SOUNDTRACK-B)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Ranjit Nair
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.